Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carvana Co (CVNA) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance

Carvana CoTrade
Nuvation Bio Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Carvana Co vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Carvana Co trades at $64.21 (market cap $69.55B), while Nuvation Bio Inc. Class A Common Stock trades at $4.96 (market cap $1.74B). The key difference: Carvana Co is far larger — about 40× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is more actively traded (9,289,619 versus 7,671,750). Which is the better fit depends on your goals — on Pluang, investors hold Carvana Co for 28 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.

CVNANUVB
Market Cap
$69.55B$1.74B
Volume
7,671,7509,289,619
Sector
Consumer CyclicalHealth
52-Week High
$95.69$9.54
52-Week Low
$56.27$3.41
Typical Hold Time
28 Days0 Days
Enterprise Value
$72.04B$1.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Carvana Co

Carvana (CVNA) trades at $64.26, up 2.39% on the day, showing resilience amid a bearish technical signal. The company reported strong revenue growth to $20.32B in 2025 with net income of $1.41B, and has beaten EPS estimates for three consecutive quarters. Positive analyst sentiment is highlighted by a consensus price target of $84.07, though technical indicators suggest near-term caution with key support at $61.

Outlook remains positive due to robust earnings beats and expansion initiatives, but risks include high debt levels and competitive pressures. The stock offers growth potential if operational execution continues, yet investors should monitor cash flow sustainability and market volatility.

Nuvation Bio Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVNA
26% Buy74% Sell
Avg holding period · 28 Days
NUVB
100% Buy0% Sell
Avg holding period · 0 Days

About Carvana Co

Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.

Read more on CVNA →

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →